Liana Fraenkel, MD, MPH
Dr
Yale University
VA Connecticut Healthcare
950 Campbell Avenue
West Haven,
CT
USA
06516
Email:
liana.fraenkel@yale.edu
Papers:
1A-2
THE INFLUENCE OF RISK PRESENTATION FORMAT ON WILLINGNESS TO START A MEDICATION
1A-3
DO VISUAL DECISION AIDS HELP PATIENTS CORRECTLY DIFFERENTIATE BETWEEN A 2% VS A 0.2% RISK?
2D-3
THE ROLE OF AMBIGUITY IN LUNG CANCER SCREENING DECISION MAKING
3G-3
MODELING THE GIST OF RISKS, BENEFITS, AND VALUES IN PATIENTS' WILLINGNESS TO START MEDICATIONS
5M-3
ARE CULTURALLY TARGETED PATIENT DECISION AIDS MORE EFFECTIVE? UNEXPECTED RESULTS FROM THREE RANDOMIZED EXPERIMENTS
INFORMATION NEEDS FOR OLDER WOMEN WITH EARLY STAGE BREAST CANCER WHEN MAKING RADIOTHERAPY DECISIONS
PATIENTS OVERESTIMATE THEIR RISK, BUT THE MAGNITUDE DECREASES WHEN INFORMATION COMES FROM THEIR DOCTOR WITHOUT PATIENT'S OWN ESTIMATIONS
UTILIZATION OF CONTINUOUS “SPINNERS” TO COMMUNICATE RISK